BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6797869)

  • 1. [The influence of long-term medication with the LH-RH analogue buserelin on the regulation of the menstrual cycle (author's transl)].
    Hardt W; Schmidt-Gollwitzer M; von der Ohe M; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1981 Nov; 41(11):791-6. PubMed ID: 6797869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term administration of Buserelin, an LH-RH analogue, and its influence on the menstrual cycle (author's transl)].
    Hardt W; Schmidt-gollwitzer M
    Contracept Fertil Sex (Paris); 1983 Jan; 11(1):17-23. PubMed ID: 12311954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with a LH-RH-agonist: a new contraceptive method?
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J
    Acta Eur Fertil; 1981 Sep; 12(3):275-6. PubMed ID: 6803498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; von der Ohe M; Nevinny-Stickel J
    Contraception; 1981 Feb; 23(2):187-95. PubMed ID: 6786826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C; Nillius SJ; Wide L; Lindgren A
    Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women.
    Bergquist C; Nillius SJ; Wide L
    Fertil Steril; 1982 Aug; 38(2):190-3. PubMed ID: 6809500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of amenorrhea with a LH-RH-analogue as nasal spray].
    Friedrich F; Kemeter P
    Wien Med Wochenschr; 1982 Jan; 132(1):19-21. PubMed ID: 6803443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endometrial biopsy in hormonal imbalance].
    Gompel C; Muller C
    Ann Pathol; 1983; 3(2):101-17. PubMed ID: 6347212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifertility effects of an LH-RH analogue in male rats and dogs.
    Sandow J; von Rechenberg W; Baeder C; Engelbart K
    Int J Fertil; 1980; 25(3):213-21. PubMed ID: 6108932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.
    Lemay A; Quesnel G
    Fertil Steril; 1982 Sep; 38(3):376-9. PubMed ID: 6214431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological studies of human endometrium during continuous LH-RH agonist treatment.
    Lundkvist O; Bergquist C
    Int J Fertil; 1986; 30(4):65-70. PubMed ID: 2890599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term regulation of LH and FSH secretion in cyclic women. III. Effects of varying doses of two consecutive LH-RH injections on pituitary and ovarian response.
    Römmler A; Viebahn C; Schwartz U; Hammerstein J
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):394-402. PubMed ID: 371321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ; Bergquist C; Wide L
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin release during repeated administration of d-Leu6 des Gly10-LH-RH-EA at different stages of the menstrual cycle and in functional amenorrhea.
    Hanker JP; Knippenberg J; Kastin AJ; Wickings EJ; Schally AV; Coy DH; Schneider HP
    Int J Fertil; 1980; 25(1):7-17. PubMed ID: 6104647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.